Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer.
La Civita E, Carbone G, Sicignano E, Crocetto F, Terracciano D. La Civita E, et al. Among authors: crocetto f. J Basic Clin Physiol Pharmacol. 2023 Mar 27;34(3):245-247. doi: 10.1515/jbcpp-2023-0059. eCollection 2023 May 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 36972321 No abstract available.
Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
Capece M, Spirito L, La Rocca R, Napolitano L, Buonopane R, Di Meo S, Sodo M, Bracale U, Longo N, Palmieri A, Fusco F, Verze P, Califano G, Crocetto F, Imbimbo C, Mirone V, Imperatore V, Creta M. Capece M, et al. Among authors: crocetto f. Arch Ital Urol Androl. 2020 Apr 6;92(1):17-20. doi: 10.4081/aiua.2020.1.17. Arch Ital Urol Androl. 2020. PMID: 32255316 Free article.
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
Buonerba C, Ferro M, Dolce P, Crocetto F, Verde A, Lucarelli G, Scafuri L, Facchini S, Vaia A, Marinelli A, Terracciano D, Montella L, Longo N, Imbimbo C, Mirone V, Di Lorenzo G, De Placido S, Sonpavde G. Buonerba C, et al. Among authors: crocetto f. Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23. Crit Rev Oncol Hematol. 2020. PMID: 32474391
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Ferro M, Lucarelli G, Crocetto F, Dolce P, Verde A, La Civita E, Zappavigna S, de Cobelli O, Di Lorenzo G, Facchini BA, Scafuri L, Onofrio L, Porreca A, Busetto GM, Sonpavde G, Caraglia M, Klain M, Terracciano D, De Placido S, Buonerba C. Ferro M, et al. Among authors: crocetto f. Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13. Crit Rev Oncol Hematol. 2021. PMID: 33316417
Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF-1 upregulation of TUBB2B beta-tubulin isoform.
Liotti A, La Civita E, Cennamo M, Crocetto F, Ferro M, Guadagno E, Insabato L, Imbimbo C, Palmieri A, Mirone V, Liguoro P, Formisano P, Beguinot F, Terracciano D. Liotti A, et al. Among authors: crocetto f. Prostate. 2021 May;81(7):407-417. doi: 10.1002/pros.24117. Epub 2021 Mar 18. Prostate. 2021. PMID: 33734457 Free PMC article.
Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.
Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Ferro M, et al. Among authors: crocetto f. J Pers Med. 2021 Mar 23;11(3):237. doi: 10.3390/jpm11030237. J Pers Med. 2021. PMID: 33806972 Free PMC article. Review.
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis.
Ferro M, de Cobelli O, Musi G, Lucarelli G, Terracciano D, Pacella D, Muto T, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Crocerossa F, Farhan ARA, Autorino R, Vartolomei MD, Muto M, Marchioni M, Mari A, Scafuri L, Minervini A, Longo N, Chiancone F, Perdona S, De Placido P, Verde A, Catellani M, Luzzago S, Mistretta FA, Ditonno P, Caputo VF, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Hurle R, Crisan N, Manfredi M, Porpiglia F, Di Lorenzo G, Crocetto F, Buonerba C. Ferro M, et al. Among authors: crocetto f. Front Oncol. 2021 May 11;11:651745. doi: 10.3389/fonc.2021.651745. eCollection 2021. Front Oncol. 2021. PMID: 34046347 Free PMC article.
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.
Ferro M, Babă DF, de Cobelli O, Musi G, Lucarelli G, Terracciano D, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Rocco P, Scarpa RM, Abu Farhan AR, Autorino R, Brescia A, Marchioni M, Mari A, Minervini A, Longo N, Chiancone F, Perdona' S, Barone B, Placido P, Catellani M, Bottero D, Ditonno P, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Smelzo S, Hurle R, Crisan N, Manfredi M, Porpiglia F, Crocetto F, Buonerba C, Danilesco A, Vartolomei MD. Ferro M, et al. Among authors: crocetto f. Future Sci OA. 2021 Apr 20;7(7):FSO709. doi: 10.2144/fsoa-2021-0008. eCollection 2021 Aug. Future Sci OA. 2021. PMID: 34258022 Free PMC article.
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy.
Ferro M, Lucarelli G, de Cobelli O, Dolce P, Terracciano D, Musi G, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Crocerossa F, Abu Farhan AR, Autorino R, Vartolomei MD, Marchioni M, Mari A, Minervini A, Longo N, Celentano G, Chiancone F, Perdonà S, Del Prete P, Ditonno P, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Hurle R, Crisan N, Manfredi M, Porpiglia F, Ribera D, De Placido P, Facchini S, Scafuri L, Verde A, Di Lorenzo G, Cosimato V, Luciano A, Caputo VF, Crocetto F, Buonerba C. Ferro M, et al. Among authors: crocetto f. Future Oncol. 2021 Oct;17(30):3987-3994. doi: 10.2217/fon-2020-1298. Epub 2021 Jul 19. Future Oncol. 2021. PMID: 34278815
175 results